Abiopharma

New Form 8-K - enGene Holdings Inc. Filed: 2025-06-09 AccNo: 0000950170-25-083444 Size: 2 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 9.01: Financial Statements and Exhibits